Sitagliptin

Last Updated: 04/28/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 3774 publications

Pharmacologic DPP-4 inhibition promotes CD8⁺ T cell metabolic fitness to enhance anti-tumor activity.

Pharmacologic DPP-4 inhibition promotes CD8⁺ T cell metabolic fitness to enhance anti-tumor activity.

Journal: bioRxiv : the preprint server for biology

Published: April 10, 2026

Development and validation of an RP-HPLC method for simultaneous determination of sitagliptin and valsartan.

Development and validation of an RP-HPLC method for simultaneous determination of sitagliptin and valsartan.

Journal: Pakistan journal of pharmaceutical sciences

Published: April 04, 2026

ILK (Integrin-Linked Kinase)-Dependent Modulation of DPP4 (Dipeptidyl Peptidase 4) Prevents Progression of Calcific Aortic Valve Disease.

ILK (Integrin-Linked Kinase)-Dependent Modulation of DPP4 (Dipeptidyl Peptidase 4) Prevents Progression of Calcific Aortic Valve Disease.

Journal: Arteriosclerosis, thrombosis, and vascular biology

Published: April 02, 2026

TIP26-314: Targeting Macrophage Migration Inhibitory Factor: A Phase 2 and Pharmacodynamic Study of Sitagliptin in Patients With Progressive Grade 4 Gliomas.

TIP26-314: Targeting Macrophage Migration Inhibitory Factor: A Phase 2 and Pharmacodynamic Study of Sitagliptin in Patients With Progressive Grade 4 Gliomas.

Journal: Journal of the National Comprehensive Cancer Network : JNCCN

Published: March 30, 2026

Acute Pancreatitis in a Young Patient With Type 2 Diabetes Mellitus Taking Sitagliptin and the Combined Oral Contraceptive Pill.

Acute Pancreatitis in a Young Patient With Type 2 Diabetes Mellitus Taking Sitagliptin and the Combined Oral Contraceptive Pill.

Journal: Cureus

Published: March 13, 2026

Effect of anti-tuberculosis drugs on the pharmacokinetics and pharmacodynamics of novel antidiabetic drugs: A scoping review.

Effect of anti-tuberculosis drugs on the pharmacokinetics and pharmacodynamics of novel antidiabetic drugs: A scoping review.

Journal: Pulmonology

Published: March 10, 2026

Spiropyrrolizine derivatives as multitarget antidiabetic agents in obese type 2 diabetes: integrated in silico, in vitro, and in vivo evaluation of DPP-4 inhibition and hepatic enzyme modulation.

Spiropyrrolizine derivatives as multitarget antidiabetic agents in obese type 2 diabetes: integrated in silico, in vitro, and in vivo evaluation of DPP-4 inhibition and hepatic enzyme modulation.

Journal: Future medicinal chemistry

Published: February 26, 2026

Improving glucose tolerance in obese rats: the role of Jinlida granules ( ) in gut microbiota modulation.

Improving glucose tolerance in obese rats: the role of Jinlida granules ( ) in gut microbiota modulation.

Journal: Journal of traditional Chinese medicine = Chung i tsa chih ying wen pan

Published: February 25, 2026

SGLT2 Inhibitor Use and Cardiorenal Outcomes in Type 2 Diabetes With Liver Cirrhosis.

SGLT2 Inhibitor Use and Cardiorenal Outcomes in Type 2 Diabetes With Liver Cirrhosis.

Journal: JAMA network open

Published: February 23, 2026

Elucidating Unknown Organofluorine in Municipal Wastewater: A Mass Balance Approach including Fluorinated Pharmaceuticals.

Elucidating Unknown Organofluorine in Municipal Wastewater: A Mass Balance Approach including Fluorinated Pharmaceuticals.

Journal: Environmental science & technology

Published: February 20, 2026

Assessment of Drug Dosing Appropriateness in Hospitalized Chronic Kidney Disease Patients with Cardiovascular Diseases: A Cross-Sectional Study in the Al-Baha Region, Saudi Arabia (2023-2025).

Assessment of Drug Dosing Appropriateness in Hospitalized Chronic Kidney Disease Patients with Cardiovascular Diseases: A Cross-Sectional Study in the Al-Baha Region, Saudi Arabia (2023-2025).

Journal: Journal of clinical medicine

Published: February 11, 2026

Integrative Pharmacological and Computational Analysis of Abelmoschus esculentus Phytochemicals: Enzyme Inhibition, Molecular Docking, and Dynamics Simulation Against Key Antidiabetic Targets.

Integrative Pharmacological and Computational Analysis of Abelmoschus esculentus Phytochemicals: Enzyme Inhibition, Molecular Docking, and Dynamics Simulation Against Key Antidiabetic Targets.

Journal: Life (Basel, Switzerland)

Published: February 09, 2026

Showing 1-12 of 3,774

Last Updated: 04/28/2026